TransEnterix Senhance Surgical System

The TransEnterix Senhance Surgical System is a multi-arm robotic platform designed to enhance surgeon control over standard laparoscopic instruments in minimally invasive procedures through features like force feedback and eye-tracking. It aims to achieve comparable clinical outcomes to existing laparoscopic and robotic techniques across gynecological, colorectal, cholecystectomy, and inguinal hernia repair surgeries for adult patients.

The TransEnterix Senhance Surgical System is a console-based, multi-arm robotic platform designed to assist surgeons in the accurate control of laparoscopic instruments during minimally invasive procedures within the lower abdomen and pelvis. Its architecture comprises a surgeon's cockpit for inputting commands via hand and eye movements, up to three independent manipulator arms that interface with the endoscope and surgical tools, and a node unit that relays signals and transmits 2D/3D video. The system incorporates several safety features, including force feedback, eye-tracking gaze stop, emergency stops, and limits on excessive force, while utilizing reusable, steam-sterilizable instruments that are adaptations of standard laparoscopic tools. This specific iteration of the Senhance System expands its indications for use to include laparoscopic cholecystectomy and inguinal hernia repair, in addition to previously established gynecological and colorectal surgeries for adult patients. Clinical data from retrospective chart reviews for these new procedures demonstrated comparable outcomes to predicate robotic systems (like the da Vinci Xi) and standard laparoscopic techniques. For cholecystectomy (40 cases), the Senhance system showed similar rates of complications, operative times, and conversions. Similarly, for inguinal hernia repair (76 procedures), results regarding complications, operative times, and patient recovery were comparable to existing methods. The system also underwent minor non-end-user-facing software revisions, including a compatibility check, an R&D mode, and an automated instrument calibration function.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the tactile force feedback feature of the Senhance system compare quantitatively to the sensory input surgeons receive during traditional laparoscopic surgery, and does this impact instrument handling precision or tissue damage rates?; Given the use of "straight stick standard laparoscopy" instruments, what are the specific ergonomic advantages or disadvantages for surgeons transitioning from traditional laparoscopy compared to systems with wristed instruments?; The document mentions "umbrella procedures" for extrapolating clinical data; what is the detailed rationale and methodology used to validate this extrapolation for less complex "covered procedures" within gynecological and colorectal specialties?; What specific training protocols are recommended for physicians to achieve proficiency with the Senhance system, particularly concerning the eye-tracking endoscope control and force feedback interpretation?; While operative times and short-term complications for cholecystectomy and inguinal hernia repair appear comparable, what is the learning curve associated with the Senhance system for these procedures, and how does it influence these metrics for new users?